Answers are grounded in this paper and cite their sources.
Screening for genetic and congenital abnormalities during pregnancy has developed over the past 10–15 years from a concept to an established aspect of modern obstetric management in response to the declining importance of other causes of infant and perinatal mortality and morbidity. This review will consider why screening is indicated for this group of conditions, the criteria for any screening programme and the current impact of prenatal screening.
No takes yet. Share an insight, caveat, or question.
J. M. Connor (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: